July 08, 2020 M. Pauliina Margolis, M.D., Ph.D.
Dr. Pauliina Margolis joined Keystone Heart as Vice President and Chief Medical Officer in 2012. Prior to Keystone Heart, Dr. Margolis served as CMO and VP Scientific Affairs at Volcano Corporation 2001-2012. Formerly, she served as medical consultant to different start-up companies including Transvascular Inc, Point BioMedical, PharmaSonics, American Biosciencies, Target Therapeutics, and VasConnect, different Venture Capital firms and larger companies in CA, Silicon Valley, USA. Dr. Margolis has authored over 100 original scientific publications including several reviews and book chapters, holds over 20 patents. Her university lectures and teaching include Human Physiology, Oulu, Finland, Cardiology, Cincinnati, USA and Cardiology Edinburgh, UK. Dr. Margolis did her post-doctoral fellowship in experimental coronary ischemia in the University of Cincinnati, UK, specialty in internal medicine, University of Helsinki, Finland, interventional cardiology training, University of Edinburgh, UK, and Early Business Development and Executive Management at Stanford Business School, Stanford University, CA, USA.